Nobuhiko Kubo
- Immunology top 10%
- Epidemiology
- Molecular Biology
- Surgery
- Immunology and Allergy top 10%
- Co-authors
- William A. BoisvertLinda K. CurtissLaura J. PinderskiJudith A. BerlinerMichael C. FishbeinHilde CheroutreMichael P. FischbeinGanesamoorthy Subbanagounder
- Topics
- Atherosclerosis and Cardiovascular Diseases (8 papers)Cancer, Lipids, and Metabolism (3 papers)Lipoproteins and Cardiovascular Health (3 papers)
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Nobuhiko Kubo
21 papers receiving 575 citations
Peers
Comparison fields: 5 of 68
- Immunology 367
- Epidemiology 186
- Molecular Biology 166
- Surgery 111
- Immunology and Allergy 64
Countries citing papers authored by Nobuhiko Kubo
This map shows the geographic impact of Nobuhiko Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiko Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiko Kubo more than expected).
Fields of papers citing papers by Nobuhiko Kubo
This network shows the impact of papers produced by Nobuhiko Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiko Kubo. The network helps show where Nobuhiko Kubo may publish in the future.
Co-authorship network of co-authors of Nobuhiko Kubo
This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiko Kubo. A scholar is included among the top collaborators of Nobuhiko Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiko Kubo. Nobuhiko Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | Structural analysis using atomic force microscopy of the surface of red blood cells to detect anti-red blood cell autoantibody. | 1 |
| 4 | 10 | |
| 5 | 290 | |
| 6 | [Evaluation of LDL-cholesterol measurement]. | 1 |
| 7 | 1 | |
| 8 | 94 | |
| 9 | 23 | |
| 10 | 4 | |
| 11 | 17 | |
| 12 | 43 | |
| 13 | 28 | |
| 14 | 3 | |
| 15 | 14 | |
| 16 | 16 | |
| 17 | 18 | |
| 18 | 2 | |
| 19 | 10 | |
| 20 | 3 |
About Nobuhiko Kubo
Nobuhiko Kubo is a scholar working on Immunology and Allergy, Immunology and Parasitology, having authored 21 papers that have together received 588 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (8 papers), Cancer, Lipids, and Metabolism (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Immunology (367 citations), Immunology and Allergy (64 citations) and Epidemiology (186 citations). Nobuhiko Kubo has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include William A. Boisvert, Linda K. Curtiss, Laura J. Pinderski, Judith A. Berliner, Michael C. Fishbein, Hilde Cheroutre, Michael P. Fischbein, Ganesamoorthy Subbanagounder, Natalie K. Schiller and Ikunosuke Sakurabayashi. Their work appears in journals such as Circulation, Circulation Research and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.